Development of a Risk Prediction Nomogram for Carotid Restenosis in the One Year RECAST Registry.

Carotid artery disease Endovascular procedure Nomogram Restenosis Stenting Stroke

Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
25 May 2024
Historique:
received: 25 08 2023
revised: 23 04 2024
accepted: 21 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 27 5 2024
Statut: aheadofprint

Résumé

Long term benefit of carotid angioplasty and stenting (CAS) can be reduced by recurrent stroke related to in stent restenosis (ISR). An individualised predictive tool is needed to identify ISR events. A nomogram for individual risk assessment of ISR ≥ 70% after CAS is proposed. A national observational, prospective, multicentre registry was conducted between January 2015 and December 2020. Cohorts of patients with symptomatic or asymptomatic severe carotid stenosis who underwent CAS were included with a follow up of at least 1 year after CAS. Duplex ultrasound was used to assess in stent restenosis. Pre-operative factors were compared between the non-ISR and ISR groups. Kaplan-Meier and Cox regression were used for variable selection. The nomogram was formulated and validated by concordance indices and calibration curves. An in stent restenosis risk table was generated for risk stratification. A total of 354 patients were included in the analysis. The ISR rate of ≥ 70% was 7.6% (n = 27). Peripheral arterial disease (hazard ratio [HR] 3.18, 95% confidence interval [CI] 1.23 - 8.24, p = .017), anterior communicating artery absence (HR 3.38, 95% CI 1.27 - 8.94, p = .016), diabetes mellitus (HR 3.34, 95% CI 1.21 - 9.26, p = .020), female sex (HR 2.99, 95% CI 1.04 - 8.60, p = .041), and pre-procedure pathologic ultrasound vasoreactivity (HR 3.87, 95% CI 1.43 -10.50, p = .008), as independent risk factors for ISR of ≥ 70%, were included in the nomogram. Concordance index at 12 and 24 months was 0.83. In low risk groups, ISR of ≥ 70% occurred in 4.8% of patients during follow up compared with 56.2% of patients in the high risk groups (p < .001). The nomogram and risk evaluation score have good predictive ability for ISR. They can be used as practical clinical tools for individualised risk assessment.

Identifiants

pubmed: 38802040
pii: S1078-5884(24)00460-X
doi: 10.1016/j.ejvs.2024.05.033
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Elena Zapata-Arriaza (E)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain.

Marta Aguilar Pérez (M)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain.

Asier De Albóniga-Chindurza (A)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain.

Manuel Medina (M)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain; Department of Neurology, University Hospital Virgen del Rocio, Seville, Spain.

Joan Montaner (J)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain.

Francisco Moniche (F)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain; Department of Neurology, University Hospital Virgen del Rocio, Seville, Spain.

Alejandro González (A)

Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/Macarena/CSIC/University of Seville, Seville, Spain; Interventional Neuroradiology Department, University Hospital Virgen del Rocio, Seville, Spain. Electronic address: ggjandro@gmail.com.

Classifications MeSH